Profiling: "Editorial on 'survival after progression in patients with follicular lymphoma: Analysis of prognostic factors", by S. Montoto et. al. (Ann Oncol 2002; 13: 523-530)

Annals of Oncology

Volumn 13, Issue 4, 2002, Pages 499-500

  McLaughlin, P ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; BETA 2 MICROGLOBULIN; MONOCLONAL ANTIBODY; NUCLEOSIDE ANALOG; PROTEIN BCL 2;

ADVANCED CANCER; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; EDITORIAL; FOLLICULAR LYMPHOMA; GENE EXPRESSION; HUMAN; MEDICAL DECISION MAKING; MOLECULAR GENETICS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME;

DISEASE PROGRESSION; HUMANS; LYMPHOMA, FOLLICULAR; MODELS, THEORETICAL; PATIENT CARE PLANNING; PROGNOSIS; SALVAGE THERAPY; SURVIVAL;

EID: 0036237729     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdf149     Document Type: Editorial

References (14)

1. Survival after progression in patients with follicular lymphoma: Analysis of prognostic factors
2. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project
3. Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma
4. Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: Clinical and molecular evaluation
5. Therapy of relapsed or refractory low-grade follicular lymphomas: Factors associated with complete remission, survival and time to treatment failure
6. Survival after relapse of low-grade non-Hodgkin's lymphoma: Implications for marrow transplantation
7. Follicular lymphoma: Prognostic factors for response and survival
8. Allogeneic bone marrow transplantation for low-grade lymphoma
9. High-dose therapy and autologous bone marrow transplant for follicular lymphoma in first complete or partial remission: Results of a phase II clinical trial
10. Transplant-lite: Induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies
11. Diffuse large-cell lymphoma
12. The clinical significance of molecular response in indolent follicular lymphomas
13. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
14. Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arrays